Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome

Completed · Phase 2

Conditions studied: Neonatal Abstinence Syndrome

In brief

To test the hypothesis that the combination of the tincture of opium (DTO) and clonidine will be more effective in treating infants with neonatal abstinence syndrome (opioid withdrawal) than tincture of opium (DTO) alone.

Key facts

Study ID

NCT00510016

Run by

National Institute on Drug Abuse (NIDA)

People needed

80

Starts

2002-07-01

Expected to finish

2005-12-01

Last updated by the study team

2017-01-11

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• < 35 weeks gestational age
• Intrauterine growth retardation defined as <5%tile of gestational age
• postnatal treatment with barbiturates or benzodiazepines,
• major congenital anomalies
• major concomitant medical illness requiring oxygen therapy, intravenous fluids or medications.
• breastfed infants

Where it is running

• Johns Hopkins Medical Institutions — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.